Sutro Biopharma (STRO) Non-cash Items (2016 - 2025)

Sutro Biopharma's Non-cash Items history runs 10 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• In Q4 2025, Non-cash Items changed N/A year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.2 million, down 80.8% from the prior year.
• Non-cash Items came in at $1.2 million for Q4 2025 at Sutro Biopharma, down from $5.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $58.1 million in Q1 2021 to a low of $180000.0 in Q4 2023.
• A 5-year average of $9.5 million and a median of $5.5 million in 2023 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items surged 2897.04% in 2021 and tumbled 98.11% in 2022, its largest moves.
• Sutro Biopharma's Non-cash Items stood at $15.0 million in 2021, then slumped by 85.38% to $2.2 million in 2022, then tumbled by 91.77% to $180000.0 in 2023, then jumped by 3427.65% to $6.3 million in 2024, then sank by 80.72% to $1.2 million in 2025.
• According to Business Quant data, Non-cash Items over the past three periods registered $1.2 million, $5.2 million, and $6.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison